X

Xenon Pharmaceuticals
D

XENE

33.915
USD
-0.53
(-1.52%)
قبل الجلسة·34.030USD+0.115(+0.34%)
حجم التداول
95,815
الربح لكل سهم
-4
العائد الربحي
-
P/E
-7
حجم السوق
3,284,343,251
أصول ذات صلة

العنوان: Xenon Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.